Sybille
Sybille Buchwald-Werner, Duesseldorf DE
Patent application number | Description | Published |
---|---|---|
20080220101 | COMPOSITIONS OF EXTRACTS OF ALOE FOR ORAL ADMINISTRATION - Compositions containing extracts of | 09-11-2008 |
20100297266 | Preparations and methods for textile and or fiber surface finishing, surface finished articles prepared thereby, and uses therefor - Disclosed are food compositions, comprising aqueous extracts of | 11-25-2010 |
Sybille Buchwald-Werner, Dusseldorf DE
Patent application number | Description | Published |
---|---|---|
20130303468 | VICENIN 2 AND ANALOGUES THEREOF FOR USE AS AN ANTISPASMODIC AND/OR PROKINETIC AGENT - Provided are compositions comprising an active ingredient having antispasmodic and/or prokinetic activity, preferably vicenin 2 or biologically active analogues thereof. | 11-14-2013 |
20140322198 | COMPOSITION COMPRISING VICENIN-2 HAVING A BENEFICIAL EFFECT ON NEUROLOGICAL AND/OR COGNITIVE FUNCTION - The invention relates to an active ingredient and/or to a composition having beneficial effect on neurological and cognitive functions. | 10-30-2014 |
Sybille Cornelsen, Ratingen DE
Patent application number | Description | Published |
---|---|---|
20130004449 | Conditioner And Conditioning Shampoo Compound Containing Pentaerythritol Ester - The invention relates to a cosmetic preparation containing (a) esters of fatty acids having 6 to 12 carbon atoms with pentaerythritol and (b) silicones. | 01-03-2013 |
20130012423 | Use Of Cleaning Agents Containing Microemulsions That Contain Wax - The invention relates to the use of microemulsions, containing (a) at least one alkyl(oligo)glycoside, (b) at least one co-surfactant different from (a), (c) at least one water-insoluble organic oil component, (d) at least one wax, and (e) water, to produce cleaning agents, and aqueous hand dishwashing detergents, containing anionic and amphoteric surfactants and, in amounts from 0.2 to 10 wt % relative to the total weight of the hand dishwashing detergents, a microemulsion according to the description in claim | 01-10-2013 |
20150071867 | Hair Cosmetic Composition Which Comprises A Plant Lecithin - Described is a hair cosmetic composition which comprises at least one plant lecithin, at least one anionic surfactant, and at least one fatty alcohol. | 03-12-2015 |
Sybille Froech, Mannheim DE
Patent application number | Description | Published |
---|---|---|
20120179004 | Medical monitoring network - A network for monitoring bodily functions of a patient is disclosed. The network comprises at least two distinct network nodes that can be connected to a body of the patient. At least two of the network nodes can have at least one medical function, such as, for example, a diagnostic function and/or a medication function. The network nodes can communicate directly with one another via the body of the patient and can interchange data and/or commands. | 07-12-2012 |
20120245438 | MEDICAL SYSTEM HAVING PLUG AND PLAY FUNCTION - A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step. | 09-27-2012 |
20130059536 | Method for generating a medical network - A method for setting up a medical network for carrying out at least one medical function is disclosed. The medical network comprises network nodes and the network nodes are set up for communicating with one another by an initialization step, wherein the network nodes exchange initialization information that includes information characterizing the network nodes and a self-organization step where the network nodes define their role distribution. A work step where the network carries out the medical function and the two network nodes interact in the role of distribution defined in the self-organization step. | 03-07-2013 |
Sybille Greithanner, Peiting DE
Patent application number | Description | Published |
---|---|---|
20110034672 | PURIFICATION OF NOT-GLYCOSYLATED POLYPEPTIDES - The current invention reports a method for the purification of a not-glycosylated, heterologous polypeptide, which has been recombinantly produced in a prokaryotic cell, wherein the method comprises three chromatography steps of which the first chromatography step selected from i) hydrophobic charge induction chromatography, or ii) hydrophobic interaction chromatography, or iii) affinity chromatography, or iv) ion exchange chromatography, the second chromatography step is selected from i) anion exchange chromatography, or ii) cation exchange chromatography, or iii) hydroxylapatite chromatography, or iv) hydrophobic interaction chromatography, and the a third chromatography step is selected from i) hydrophobic charge induction chromatography, or ii) anion exchange chromatography, or iii) cation exchange chromatography, or iv) hydrophobic interaction chromatography, whereby the first chromatography step is an affinity chromatography in case of polypeptides capable of interacting with metal ligands, the second chromatography step is not a hydroxylapatite chromatography step in case of polypeptides with an isoelectric point below 6.0, and the third chromatography step can be performed in flow-through mode with polypeptides having a low or high isoelectric point. | 02-10-2011 |
20130190478 | PURIFICATION OF NOT-GLYCOSYLATED POLYPEPTIDES - The current invention reports a method for the purification of a non-glycosylated, heterologous polypeptide, which has been recombinantly produced in a prokaryotic cell, wherein the method comprises three chromatography steps of which the first chromatography step selected from i) hydrophobic charge induction chromatography, or ii) hydrophobic interaction chromatography, or iii) affinity chromatography, or iv) ion exchange chromatography, the second chromatography step is selected from i) anion exchange chromatography, or ii) cation exchange chromatography, or iii) hydroxylapatite chromatography, or iv) hydrophobic interaction chromatography, and the a third chromatography step is selected from i) hydrophobic charge induction chromatography, or ii) anion exchange chromatography, or iii) cation exchange chromatography, or iv) hydrophobic interaction chromatography, whereby the first chromatography step is an affinity chromatography in case of polypeptides capable of interacting with metal ligands, the second chromatography step is not a hydroxylapatite chromatography step in case of polypeptides with an isoelectric point below 6.0, and the third chromatography step can be performed in flow-through mode with polypeptides having a low or high isoelectric point. | 07-25-2013 |
Sybille Korrodi, Kussnacht CH
Patent application number | Description | Published |
---|---|---|
20080254412 | Gingivaformer - A gingivaformer for a dental implant, wherein the gingivaformer is manufactured from a mixture of PEEK base material with a fraction of 95 to 99% by weight and at least one dye with a fraction of 1 to 5% by weight, so that the gingivaformer is flesh-colored. | 10-16-2008 |
Sybille Muller, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20150216973 | METHOD FOR THE INDUCTION OF AN IMMUNE RESPONSE - An immune response against an antigen is induced by stimulation with a two-component vaccine that includes an antiidiotypic antibody as one of the components. An immune response against an antigen is also induced by stimulation with other two-component vaccines. Stimulation by a two-component vaccine may be followed by stimulation with a monoclonal broadly neutralizing anti-HIV antibody or with one of the components of the two-component vaccine. This method of inducing immunity has applications in vaccines against infectious pathogens and in therapeutic and preventive vaccines against cancers. | 08-06-2015 |